{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:08:36Z","timestamp":1789690116430,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1053\/j.akdh.2023.09.003","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T20:01:43Z","timestamp":1720814503000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Thrombotic Microangiopathies and the Kidney"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0433-238X","authenticated-orcid":false,"given":"Anuja","family":"Java","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2340-3772","authenticated-orcid":false,"given":"Richard","family":"Burwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-5510","authenticated-orcid":false,"given":"Anthony","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1053\/j.akdh.2023.09.003_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.akdh.2023.09.003_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"issue":"Supplement 1","key":"10.1053\/j.akdh.2023.09.003_bib3","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1182\/blood-2018-99-117723","article-title":"Clinical associations, treatment, and outcomes of renal-limited thrombotic microangiopathy","volume":"132","author":"Saba","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.akdh.2023.09.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2014.00097","article-title":"Extra-renal manifestations of complement- mediated thrombotic microangiopathies","volume":"2","author":"Hofer","year":"2014","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.kint.2016.07.021","article-title":"Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney","volume":"90","author":"Buob","year":"2016","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2023.09.003_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00251-006-0142-1","article-title":"Genomic view of the evolution of the complement system","volume":"58","author":"Nonaka","year":"2006","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12474","article-title":"Evolution of the complement system: from defense of the single cell to guardian of the intravascular space","volume":"274","author":"Elvington","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1053\/j.akdh.2023.09.003_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-pathol-012615-044145","article-title":"Complement dysregulation and disease: insights from Contemporary genetics","volume":"12","author":"Liszewski","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-072211-110606","article-title":"Defective complement inhibitory function predisposes to renal disease","volume":"64","author":"Java","year":"2013","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1053\/j.akdh.2023.09.003_bib10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2215\/CJN.01710216","article-title":"All Things complement","volume":"11","author":"Thurman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.09.003_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2023.09.003_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0034-1375296","article-title":"Genetics of atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti\u2013factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.akdh.2023.09.003_bib15","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5144\/1658-3876.2011.51","article-title":"Viral-associated thrombotic microangiopathies","volume":"4","author":"da Silva","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"11","key":"10.1053\/j.akdh.2023.09.003_bib17","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1537-2995.2008.01871.x","article-title":"A severe case of atypical hemolytic uremic syndrome associated with pneumococcal infection and T activation treated successfully with plasma exchange","volume":"48","author":"Hopkins","year":"2008","journal-title":"Transfusion"},{"issue":"15","key":"10.1053\/j.akdh.2023.09.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.140711","article-title":"The complement system in COVID-19: friend and foe?","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"10.1053\/j.akdh.2023.09.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2020.00212","article-title":"An update in drug-induced thrombotic microangiopathy","volume":"7","author":"Chatzikonstantinou","year":"2020","journal-title":"Front Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.09.003_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.23960","article-title":"Drug-induced thrombotic microangiopathy: experience of the Oklahoma registry and the bloodcenter of Wisconsin","volume":"90","author":"Reese","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","article-title":"The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.akdh.2023.09.003_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: differential diagnosis","volume":"12","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"10.1053\/j.akdh.2023.09.003_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/HYPERTENSIONAHA.121.17311","article-title":"Differentiating hemolysis, elevated liver enzymes, and low platelet count syndrome and atypical hemolytic uremic syndrome in the postpartum period","volume":"78","author":"Burwick","year":"2021","journal-title":"Hypertension"},{"issue":"2S","key":"10.1053\/j.akdh.2023.09.003_bib26","doi-asserted-by":"crossref","first-page":"S1059","DOI":"10.1016\/j.ajog.2020.09.038","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"226","author":"Burwick","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal complement activation in preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1053\/j.akdh.2023.09.003_bib28","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2215\/CJN.05830519","article-title":"Complement activation and thrombotic microangiopathies","volume":"14","author":"Palomo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"issue":"7","key":"10.1053\/j.akdh.2023.09.003_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.09.003_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2019.05.014","article-title":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","volume":"96","author":"Cavero","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive Emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3899\/jrheum.220752","article-title":"The role of complement in autoimmune disease-associated thrombotic microangiopathy and the potential for therapeutics","volume":"50","author":"Java","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1053\/j.akdh.2023.09.003_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2021.05.040","article-title":"Systemic autoimmune disorders associated with thrombotic microangiopathy: a cross-sectional analysis from the French National TMA registry: systemic autoimmune disease-associated TMA","volume":"93","author":"Martis","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Yang","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1053\/j.akdh.2023.09.003_bib37","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar4016","article-title":"Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome","volume":"14","author":"Zadura","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1053\/j.akdh.2023.09.003_bib38","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","article-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review","volume":"16","author":"Lee","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1053\/j.akdh.2023.09.003_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1160\/TH11-08-0554","article-title":"Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome","volume":"107","author":"Breen","year":"2012","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11926-015-0551-y","article-title":"Recent developments in the classification, evaluation, pathophysiology, and management of scleroderma renal crisis","volume":"18","author":"Ghossein","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Okr\u00f3j","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010111130","article-title":"A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy","volume":"23","author":"El Karoui","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.09.003_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2023.09.003_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-20315-3_2","article-title":"Pathophysiology 1. Mechanisms of thrombosis in cancer patients","volume":"179","author":"Falanga","year":"2019","journal-title":"Cancer Treat Res"},{"issue":"7","key":"10.1053\/j.akdh.2023.09.003_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101081","article-title":"Thrombotic microangiopathy in oncology - a review","volume":"14","author":"Val\u00e9rio","year":"2021","journal-title":"Transl Oncol"},{"issue":"8","key":"10.1053\/j.akdh.2023.09.003_bib46","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal Allograft Biopsies-role of antibody-mediated rejection","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.ackd.2019.11.003","article-title":"Peri- and post-operative evaluation and management of atypical hemolytic uremic syndrome (aHUS) in kidney transplantation","volume":"27","author":"Java","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev"},{"issue":"8","key":"10.1053\/j.akdh.2023.09.003_bib49","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1053\/j.akdh.2023.09.003_bib50","doi-asserted-by":"crossref","first-page":"775280","DOI":"10.3389\/fmed.2021.775280","article-title":"Clinicopathologic implications of complement genetic variants in kidney transplantation","volume":"8","author":"Ren","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.09.003_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1053\/j.akdh.2023.09.003_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14740\/jh529","article-title":"Pernicious anemia presenting with pseudo thrombotic microangiopathy and falsely elevated B12 levels","volume":"8","author":"Katiyar","year":"2019","journal-title":"J Hematol"},{"key":"10.1053\/j.akdh.2023.09.003_bib53","first-page":"5576","article-title":"Vitamin B12 deficiency-related pseudo-thrombotic microangiopathy might be Misdiagnosed and treated with plasma product therapy: review of the Literature and analysis of the reported cases","volume":"130","author":"Tun","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2013.08.031","article-title":"Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency","volume":"63","author":"Cornec-Le Gall","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2023.09.003_bib55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic\u2013uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.09.003_bib56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.akdh.2023.09.003_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ajkd.2017.08.007","article-title":"Glucose-6-Phosphate dehydrogenase deficiency mimicking atypical hemolytic uremic syndrome","volume":"71","author":"Walsh","year":"2018","journal-title":"Am J Kid Dis"},{"issue":"S1","key":"10.1053\/j.akdh.2023.09.003_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44","author":"Thompson","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"23","key":"10.1053\/j.akdh.2023.09.003_bib59","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib60","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ekir.2021.03.884","article-title":"Long-term efficacy and safety of the long-acting complement C5 inhibitor ravulizumab for the treatment of atypical hemolytic uremic syndrome in adults","volume":"6","author":"Barbour","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.09.003_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.kint.2020.10.046","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome na\u00efve to complement inhibitor treatment","volume":"100","author":"Ariceta","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib62","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.kint.2020.01.035","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment","volume":"97","author":"Rondeau","year":"2020","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2023.09.003_bib63","article-title":"Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome [published online ahead of print, 2023 Jul 29]","volume":"12","author":"Mauch","year":"2023","journal-title":"J Comp Eff Res"},{"issue":"11","key":"10.1053\/j.akdh.2023.09.003_bib64","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with Paroxysmal Nocturnal Hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.09.003_bib65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobiology"},{"issue":"6","key":"10.1053\/j.akdh.2023.09.003_bib66","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ekir.2022.02.021","article-title":"The rational use of complement inhibitors in kidney diseases","volume":"7","author":"Fakhouri","year":"2022","journal-title":"Kidney Int Rep"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:54:47Z","timestamp":1722160487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2949813923000964"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.09.003","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic Microangiopathies and the Kidney","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}